419
88222226014562123
Ces8507936014570127174
Urol10497936014578115180208
2024;12827936014562121178235258
28(2):15657936014562121154212242264
69–8818557936014561120183247308
PŘEHLEDOVÉ852207016974156235334409485586692777855
ČLÁNKY1754207016981154252352436525
50.850896013356111133
Muneer1013896013388148209264319355
A,139889601336792
Kayes1520896013359113163216259
O,180989601337696
Ahmed1934896013368128219274337
HU,2300896013372143162
et249289601335592
al.261389601335379101
Molecular2745898013186144167220269327349398429
prognostic320489801316193150210268326366401423471
factors370689801312879128164220252293
in402989801312381
penile4141898013160114172194216269
cancer.444089801314999157206256288302
World4772898013191146178201260
J5063898013138
Urol.5131898013169100156180198
2009;8501048013154105160214232
27:11061048013154103117
161–167.12471048013154100145195241288337344
51.8501196013356107124
Lopes10031196013352111173229272
A,1303119601336892
Bezerra14241196013359115162216252288341
AL,17931196013368118142
Pinto1963119601335983143178237
CA,22281196013364133157
et2414119601335591
al.2533119601335379101
p5326641198013161112161
as2855119801315089
a29741198013150
new30531198013159112190
prognostic3273119801316092149209267325365400422470
factor3772119801312980128165221253
for4054119801312986118
lymph4201119801312371162221280
node45101198013159117178230
metastasis47701198013190143176226265300350389411450
in5249119801312380
penile8501348013161115173194216269
carcinoma:1140134801314999130177199256314404453470
analysis16311348013150108157179227267289328
of1980134801315887
8220881348013153104
patients22131348013161111143165217275307349
treated2583134801313466117165197248309
with29131348013179102135193
amputation31271348013150139198256290340372394452510
and36581348013150108167
bilateral3846134801316183105154186237269318341
lymphadenectomy.4208134801312371161221279328388441498552601637693783829843
J50721348013138
Urol.51311348013169100156179198
2002;8501498013154105160210227
168:11011498013154101155172
81–86.12971498013154102151206260279
52.8501646013356110132
Zargar-Shoshtari10101646013360114149210263298328380440500543603638692727752
K,1789164601336086
Spiess19021646013354115141196239281
PE,22111646013358110133
Berglund23711646013360115151211237296357419
AE,28171646013367120143
et2987164601335592
al.3106164601335378101
Clinical3235164801316385106164185234283306
Significance3569164801315172131189210236263311361419467518
of4115164801315987
p5342301648013161112162
and44201648013150108167
p16(ink4a)46151648013161106152180202259305356406432
status5075164801314176125158215255
in850179801312381
a9551798013150
contemporary10291798013149105163195246335395454486536567619
North16721798013170128160197255
American19521798013164153206238260309358416
penile23921798013161115173194216269
carcinoma2685179801314999130177199256315404453
cohort.31621798013149105164222254291310
Clin3496179801316385106164
Genitourin36841798013169123180202235291349381403461
Cancer.41691798013163112170219270301315
2016;45081798013154105153200217
14:47491798013154100117
346–351.48901798013154108163221269319365378
53.8501946013356109131
Mohanty10071946013389149210263323358413
SK,14461946013354112138
Mishra16101946013389115157217253305
SK,19421946013354112138
Bhardwaj21061946013360121173208270350403429
N,2561194601337296
et2683194601335591
al.2801194601335378101
p5329291948013161112161
and31181948013150107167
p16ink4a33121948013161106153175233278329379
as3719194801315089
predictive3836194801316092144204226274311333382434
and42971948013150108167
prognostic4491194801316193150210268326366400423471
biomar‑4989194801316183141231280311340
kers850209801314798130171
for1045209801312986118
nodal11882098013159117178226249
metastasis14612098013190144177226266300350390411450
and19362098013150108167
survival2128209801314197129181204254303326
in2478209801312381
a25842098013150
contemporary26582098013149105164196247336395454486536568619
cohort33022098013149105164222254291
of3618209801315887
penile37292098013161115173195217270
squamous40232098013141101158207296354412451
cell44992098013149100122144
carcinoma.4668209801314999130177198256314404453472
Clin5165209801316385106164
Genitourin8502248013169123180202235291349381403461
Cancer.13352248013163112170219270301315
2021;16742248013154105155202213
19:1911224801315398117
510–520.20522248013154100147205257307358376
54.8512396013356113135
Bowie10112396013359120199225280
J,1316239601334061
Singh1402239601335479139200261
S,1687239601335477
O’Hanlon1789239601337698170223283309369430
C,2243239601336488
et2356239601335592
al.2472239601335379101
A25982398013164
systematic2688239801314190131165216305354386408457
review3170239801313384133156208287
of3482239801315987
non-HPV35952398013159117175209279334389
prognostic4010239801316092149209267325365400422470
biomarkers4506239801316083141230279310357408440481
used5012239801315998151211
in5249239801312380
penile8512548013161115173194216269
squamous11442548013141101158207295354412451
cell16192548013149100123144
carcinoma.1787254801315099131177199257315404453472
Turk22832548013152102133179
J24862548013138
Urol.25482548013169100156180198
2021;27702548013154105155202212
47(5):30062548013154102126176203220
358–365.32502548013154103155212260312363380
55.8502696013357109130
Marcus10122696013388142177225285328
L,1372269601335275
Fashoyin-Aje14782696013354103146206266317343404439506532587
LA,20962696013352122146
Donoghue22742696013373134195256318379438494
M,27992696013389113
et2943269601335592
al.3066269601335378101
FDA32002698013151120180
Approval34132698013164124185217274322372395
Summary:38402698013151108197287336367419439
Pembrolizumab43112698013155106195255288344368389433492581630690
for5033269801312986119
the5184269801313492146
Treatment850284801315176127175208297350408440
of1314284801315887
Tumor14252848013151101190248280
Mutational17302848013185143176226258280338396445467
Burden-High22212848013156113145203255313347417439498556
Solid28012848013151109132154213
Tumors.30382848013151101190249281321341
Clin3403284801316385106164
Cancer35912848013163112170219270301
Res.39162848013156109149168
2021;41082848013154106155202213
27(17):43452848013154103127174218247264
4685–4689.46332848013153108162214269325380434486501
56.8502996013356112134
Chahoud10092996013364124176237297357419
J,1453299601334162
Gleber-Netto1540299601337197152215270306336410465502540599
FO,21642996013354128148
McCormick23372996013388138202260296387413461512
BZ,28742996013360119142
et3040299601335692
al.3157299601335378101
Whole-exome32842998013190149208231284318374421478568621
Sequencing39312998013151104164221274332380402460519
in4476299801312381
Penile45822998013156106164186208260
Squamous48682998013151111168217306364422461
Cell8503148013163114136158
Carcinoma10403148013163112144190212270328418467
Uncovers15383148013169127175231279331363404
Novel19743148013170128176228251
Prognostic2257314801315585142202260318358393415463
Categorization27523148013163113145196256314346369412463495517575634
and34183148013150107167
Drug36173148013171103161221
Targets3870314801315192124182234268309
Similar4211314801315172161183205253285
to4528314801313490
Head46503148013169122170229
and49113148013150108168
Neck51113148013170123172218
Squamous8503298013151110168216305364422461
Cell13353298013163114136158
Carcinoma.15173298013163113144191212270328418467486
Clin2027329801316384106164
Cancer22153298013162112170218269301
Res.25403298013155108149168
2021;27323298013154105155202213
27(9):29693298013153103127176202218
2560–2570.32113298013154107159213271318371422471489
57.8503446013357111122
Herr10043446013372128164201
HW,12363446013373166184
Morales14523446013389150186240265321364
A.1848344601336893
History1974344801317092132166223256308
of2314344801315988
bacillus24353448013161112161183205227285325
Calmette-Guerin27923448013163114136226279313350401436508567620652675733
and35583448013150109169
bladder3759344801316185134194254308340
cancer:41313448013150100158207259291311
an44743448013151109
immunotherapy46163448013123112202260318377410469522554605665713
success850359801314197146193243284323
story.1197359801314276132164216229
J14503598013138
Urol.15123598013169100157180198
2008;17343598013154105160214231
179(1):1990359801315397147175223243260
53–56.22743598013154103159210262281
58.8503746013356112135
Ishida1010374601332669129154216268
Y,1303374601335975
Agata14023746013368128180215269
Y,1695374601336075
Shibahara17953746013354114139201254315367402455
K,2275374601336085
Honjo23853746013372132193218278
T.2688374601335571
Induced2785374801312381140197246297357
expression31683748013153101161193245285325346404462
of3656374801315887
PD-1,37683748013155124160206218
a40113748013150
novel40873748013159117165217240
member43523748013190144233292346378
of4755374801315987
the4868374801313492145
immu‑50393748013123111200257290
noglobulin8503898013159117177200258318376398420477
gene13513898013160113171224
superfamily,1599389801314197157211242274325414436458506519
upon21423898013158118177235
programmed2402389801316092149209240290379468521582
cell30083898013149100122144
death.31763898013160113161193251270
EMBO34703898013151136191264
J.3758389801313856
1992;3838389801315398152202219
11(11):4081389801315495116164204225241
3887–3895.43463898013154106160210258307359411463479
59.8504046013357109128
Upadhaya10094046013372133187249309362412465
S,1505404601335477
Neftelinov16134046013373128160200254280305365426477
ST,21214046013355110126
Hodge22784046013372133195257312
J,2621404601334162
Campbell27144046013364117208270333389415440
J.3185404601334162
Challenges32804048013163121169192214266325384437477
and37904048013150108167
opportunities39894048013159119180239271308366424446480502554595
in4616404801312381
the4729404801313492145
PD1/PDL149074048013155124171203259328377421
inhibitor850419801312381138160220242275331363
clinical123741980131507293151172221270293
trial155441980131346588136158
landscape.1737419801312371129189228277326386440457
Nat22184198013170119151
Rev23944198013155108157
Drug25754198013171103162221
Discov.2820419801317194133182238286299
2022;31434198013154106155208225
21(7):33924198013154101122175204220
482–483.36364198013154109160211268322374391
60.8504346013356113135
Davidsson10084346013373125176202264306349409470
S,1501434601335477
Carlsson16014346013364117152178220263323384
J,2008434601334062
Giunchi2093434601337196156217266326351
F,2467434601335365
et2555434601335592
al.2670434601335378100
PD-L127954348013155124159210254
Expression30734348013151100160192244284324345403462
in3558434801312381
Men36624348013186139197
with38834348013179102135193
Penile41004348013155106164185207260
Cancer43844348013162112170219269301
and47094348013149107167
its489943480131235798
Associ‑50214348013164106146204254276309
ation850449801315082104162220
with10944498013180102136194
Clinical1312449801316385106164185234283305
Outcomes.16424498013173132165212268357410451470
Eur21364498013151107138
Urol22984498013169100156179
Oncol.25024498013173132181237260278
2019;28044498013154106153198217
2(2):3045449801315378130156173
214–221.32424498013153100147204251304351363
61.8504646013356104119
Udager9864646013370130180240293326
AM,13294646013367153175
Liu1521464601335275133
TY,16714646013354115129
Skala18164646013354103155178229
SL,20624646013353102124
et2203464601335489
al.230946460133527697
Frequent2424464801315078127185241292347378
PD-L128194648013155121155204246
expression3083464801315298156187236275313332388445
in3545464801312379
primary3641464801316091112198245275324
and39834648013149105163
metastatic41634648013189141172220258290338369389436
penile46164648013160112168188209259
squamous4893464801314198153200287343399437
cell850479801314997118138
carcinoma:1005479801314997126171191246302389436452
potential14744798013160117148196252282303349369
opportunities18604798013158116174232262297352408428459480530569
for2446479801312883113
immunotherapeutic25774798013122109195250306362392448499529577634686741773793839
approaches.34344798013149106164195249297343399450488506
Ann39574798013164120176
Oncol.41504798013173130176230251268
2016;44354798013153103148193209
27(9):46614798013153101122169194209
1706–1712.4887479801315395142195250295336383426442
62.8504946013356111133
Cocks10154946013363122172223269
M,13154946013388112
Taheri14594946013354100160215251277
D,1767494601337392
Ball18904946013360113139164
MW,20854946013388180198
et2314494601335591
al.2436494601335379101
Immune-checkpoint25704948013123112201259316370405456514567616662723783805863895
status3497494801314175125157215254
in3783494801312381
penile38964948013161115173195217270
squamous41984948013141100158206296354412451
cell46814948013150101123145
carcinoma:4858494801314999130177199256315405454471
a8505098013150
North9245098013170129161198256
American12045098013164153206238260309358416
cohort.16445098013149105164222254291310
Hum19785098013170127216
Pathol.22185098013155103135194252275293
2017;25355098013154106153197210
59:27695098013154102121
55–61.29145098013154103158215260272
63.8505246013356111132
De10065246013373129
Bacco11595246013360113162209268
MW,14515246013388180197
Carvalhal16725246013364117152208261286346399424
GF,21205246013371124136
MacGregor22805246013389142191262298352414474510
B,2814524601336082
et2920524601335591
al.3035524601335379101
PD-L131615248013155124160210254
and34405248013150108167
p1636325248013160105152
Expression38095248013151100161193244284324345403462
in4295524801312381
Penile44005248013156106164186208261
Squamous46855248013151111168217306364422461
Cell51715248013162114136158
Carcinoma8505398013163112144190212270328418467
From1341539801315079136225
an15915398013149107
Endemic17225398013152109168221310332380
Region.21265398013156109169191249307326
Clin2476539801316385107164
Genitourin26645398013169123181202236292350381404461
Cancer.31495398013163113170219270301315
2020;34885398013154106155207225
1837375398013154100
(3):3861539801312980105122
e254–e259.40075398013153105158212268324376429478493